Assembly, maturation, and trafficking of the γ-secretase complex in Alzheimer's disease

Current Alzheimer Research

Volumn 5, Issue 2, 2008, Pages 132-146

  Dries, Daniel R ^a   Yu, Gang ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

secretase; Alzheimer's disease; Amyloid precursor protein; Aph 1; Nicastrin; Pen 2; Presenilin; Protease

Indexed keywords

AMYLOID BETA PROTEIN; ANTERIOR PHARYNX DEFECTIVE 1 PROTEIN; GAMMA SECRETASE; NICASTRIN; PRESENILIN; PRESENILIN ENHANCER 2; PROTEIN; PROTEINASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; BINDING SITE; BIOLOGY; CATALYSIS; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; GENE MUTATION; HUMAN; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; TRANSCRIPTION REGULATION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; HUMANS; PEPTIDE HYDROLASES; PROTEIN CONFORMATION;

EID: 42149109088     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720508783954695     Document Type: Review

References (175)

1. Goedert M and Spillantini MG. A century of Alzheimer's disease. Science 314(5800): 777-81(2006).
2. Glenner GG and Wong CW. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 122(3): 1131-5 (1984).
3. Glenner GG and Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120(3): 885-90 (1984).
4. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325(6106): 733-6 (1987).
5. Tanzi RE, Gusella JF, Watkins PC, Bruns GA, St George-Hyslop P, Van Keuren ML, et al. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235(4791): 880-4(1987).
6. Goldgaber D, Lerman MI, McBride OW, Saffiotti U and Gajdusek DC. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235(4791): 877-80 (1987).
7. Robakis NK, Wisniewski HM, Jenkins EC, Devine-Gage EA, Houck GE, Yao XL, et al. Chromosome 21q21 sublocalisation of gene encoding beta-amyloid peptide in cerebral vessels and neuritic (senile) plaques of people with Alzheimer disease and Down syndrome. Lancet 1(8529): 384-5 (1987).
8. Hardy J. APP Mutations Directory. Available from: http://www.alzforum. org/res/com/mut/app/default. asp [Cited 2007 June 1] (2001).
9. Kang J and Muller-Hill B. Differential splicing of Alzheimer's disease amyloid A4 precursor RNA in rat tissues: PreA4 (695) mRNA is predominantly produced in rat and human brain. Biochem Biophys Res Commun 166(3): 1192-200 (1990).
10. Zheng H and Koo EH. The amyloid precursor protein: beyond amyloid. Mol Neurodegener 1: 5 (2006).
11. Anliker B and Muller U. The functions of mammalian amyloid precursor protein and related amyloid precursor-like proteins. Neurodegener Dis 3(4-5): 239-46 (2006).
12. Cao XW and Sudhof TC. A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293(5527): 115-120 (2001).
13. De Strooper B and Annaert W. Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci 113 (Pt 11): 1857-70 (2000).
14. Sisodia SS and St George-Hyslop PH. gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat Rev Neurosci 3(4): 281-90 (2002).
15. Lichtenthaler SF. Ectodomain shedding of the amyloid precursor protein: cellular control mechanisms and novel modifiers. Neurodegener Dis 3 (4-5): 262-9 (2006).
16. Nyborg AC, Ladd TB, Zwizinski CW, Lah JJ and Golde TE. Sortilin, SorCS1b, and SorLA Vps10p sorting receptors, are novel gamma-secretase substrates. Mol Neurodegener 1: 3 (2006).
17. Kopan R and Ilagan MX. Gamma-secretase: proteasome of the membrane? Nat Rev Mol Cell Biol 5(6): 499-504 (2004).
18. Struhl G and Adachi A. Requirements for presenilin-dependent cleavage of notch and other transmembrane proteins. Molecular Cell 6(3): 625-636 (2000).
19. Selkoe D and Kopan R. Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci 26: 565-97 (2003).
20. Wang R, Sweeney D, Gandy SE and Sisodia SS. The profile of soluble amyloid beta protein in cultured cell media. Detection and quantification of amyloid beta protein and variants by immunoprecipitation-mass spectrometry. J Biol Chem 271(50): 31894-902 (1996).
21. Zhao G, Cui MZ, Mao G, Dong Y, Tan J, Sun L, et al. gamma-Cleavage is dependent on zeta-cleavage during the proteolytic processing of amyloid precursor protein within its transmembrane domain. J Biol Chem 280(45): 37689-97 (2005).
22. Walsh DM and Selkoe DJ. Abeta Oligomers - a decade of discovery. J Neurochem 101(5): 1172-84 (2007).
23. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13(1): 45-53 (1994).
24. Haass C and Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8(2): 101-12 (2007).
25. Isacson O, Seo H, Lin L, Albeck D and Granholm AC. Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh. Trends Neurosci 25(2): 79-84 (2002).
26. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17(5): 1005-13 (1996).
27. Wolfe MS and Kopan R. Intramembrane proteolysis: theme and variations. Science 305(5687): 1119-23 (2004).
28. Lichtenthaler SF and Steiner H. Sheddases and intramembrane-cleaving proteases: RIPpers of the membrane, Symposium on Regulated Intramembrane Proteolysis. EMBO Rep (6): 537-41 (2007).
29. Brown MS, Ye J, Rawson RB and Goldstein JL. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100(4): 391-8 (2000).
30. Xia W and Wolfe MS. Intramembrane proteolysis by presenilin and presenilin-like proteases. J Cell Sci 116(Pt 14): 2839-44 (2003).
31. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269(5226): 973-7 (1995).
32. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KA, Weber JL, et al. A familial Alzheimer's disease locus on chromosome 1. Science 269(5226): 970-3 (1995).
33. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimers-Disease in Kindreds with Missense Mutations in a Gene on Chromosome-1 Related to the Alzheimers-Disease Type-3 Gene. Nature 376(6543): 775-778 (1995).
34. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a Gene Bearing Missense Mutations in Early-Onset Familial Alzheimers-Disease. Nature 375(6534): 754-760 (1995).
35. Yu G, Chen F, Levesque G, Nishimura M, Zhang DM. , Levesque L, et al. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin. J Biol Chem 273(26): 16470-5 (1998).
36. Capell A, Grunberg J, Pesold B, Diehlmann A, Citron M, Nixon R, et al. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex. J Biol Chem 273(6): 3205-11 (1998).
37. Seeger M, Nordstedt C, Petanceska S, Kovacs DM, Gouras GK, Hahne S, et al. Evidence for phosphorylation and oligomeric assembly of presenilin 1. Proc Natl Acad Sci USA 94(10): 5090-4 (1997).
38. Li YM, Lai MT, Xu M, Huang Q, DiMuzio-Mower J, Sardana MK, et al. Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state. Proc Natl Acad Sci USA 97(11): 6138-43 (2000).
39. Yu G, Chen F, Nishimura M, Steiner H, Tandon A, Kawarai T, et al. Mutation of conserved aspartates affects maturation of both aspartate mutant and endogenous presenilin 1 and presenilin 2 complexes. J Biol Chem 275(35): 27348-53 (2000).
40. Edbauer D, Winkler E, Regula JT, Pesold B, Steiner H, and Haass C. Reconstitution of gamma-secretase activity. Nature Cell Biology 5(5): 486-488 (2003).
41. Fraering PC, Ye WJ, Strub JM, Dolios G, LaVoie MJ, Ostaszewski BL, et al. Purification and characterization of the human gammasecretase complex. Biochemistry 43(30): 9774-9789 (2004).
42. Hayashi I, Urano Y, Fukuda R, Isoo N, Kodama T, Hamakubo T, et al. Selective reconstitution and recovery of functional gamma-secretase complex on budded baculovirus particles. Journal of Biological Chemistry 279(36): 38040-38046 (2004).
43. Shah S, Lee SF, Tabuchi K, Hao YH, Yu C, LaPlant Q, et al. Nicastrin functions as a gamma-secretase-substrate receptor. Cell 122(3): 435-47 (2005).
44. Zhang LL, Lee JL, Song LX, Sun XY, Shen J, Terracina G, et al. Characterization of the reconstituted gamma-secretase complex from Sf9 cells co-expressing presenilin 1, nacastrin, aph-1a, and pen-2. Biochemistry 44(11): 4450-4457 (2005).
45. Kimberly WT, LaVoie MJ, Ostaszewski BL, Ye W, Wolfe MS, and Selkoe DJ. Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc Natl Acad Sci USA 100 (11): 6382-7 (2003).
46. Lazarov VK, Fraering PC, Ye W, Wolfe MS, Selkoe DJ and Li H. Electron microscopic structure of purified, active gamma-secretase reveals an aqueous intramembrane chamber and two pores. Proc Natl Acad Sci USA 103 (18): 6889-94 (2006).
47. Ogura T, Mio K, Hayashi I, Miyashita H, Fukuda R, Kopan R. et al. Three-dimensional structure of the gamma-secretase complex. Biochem Biophys Res Commun 343(2): 525-34? (2006).
48. Sato C, Morohashi Y, Tomita T and Iwatsubo T. Structure of the catalytic pore of gamma-secretase probed by the accessibility of substituted cysteines. J Neurosci 26(46): 12081-8 (2006).
49. Tolia A, Chavez-Gutierrez L and De Strooper B. Contribution of presenilin transmembrane domains 6 and 7 to a water-containing cavity in the gamma-secretase complex. J Biol Chem 281(37): 27633-42 (2006).
50. Jozwiak K, Zekanowski C and Filipek S. Linear patterns of Alzheimer's disease mutations along alpha-helices of presenilins as a tool for PS-1 model construction. J Neurochem 98(5): 1560-72 (2006).
51. St George-Hyslop PH, Haines JL, Farrer LA, Polinsky R, Van Broeckhoven C, Goate A, et al. Genetic linkage studies suggest that Alzheimer's disease is not a single homogeneous disorder. FAD Collaborative Study Group Nature 347(6289): 194-7 (1990).
52. Tanzi RE, St George-Hyslop PH, Haines JL, Polinsky RJ, Nee L, Foncin JF, et al. The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid beta-protein gene. Nature 329(6135): 156-7 (1987).
53. Hardy J. Presenilin Mutations Directory. Available from: http://www. alzforum.org/res/com/mut/pre/default. asp. [Cited 2007 June 1] (2007).
54. Crook R, Ellis R, Shanks M, Thal LJ, Perez-Tur J, Baker M, et al. Early-onset Alzheimer's disease with a presenilin-1 mutation at the site corresponding to the Volga German presenilin-2 mutation. Ann Neurol 42(1): 124-8 (1997).
55. Perez-Tur J, Croxton R, Wright K, Phillips H, Zehr C, Crook R, et al. A further presenilin 1 mutation in the exon 8 cluster in familial Alzheimer's disease. Neurodegeneration 5(3): 207-12 (1996).
56. Tu H, Nelson O, Bezprozvanny A, Wang Z, Lee SF, Hao YH, et al. Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 126(5): 981-93 (2006).
57. Vetrivel KS, Zhang YW, Xu H and Thinakaran G. Pathological and physiological functions of presenilins. Mol Neurodegener 1: 4 (2006).
58. Brunkan AL and Goate AM. Presenilin function and gamma-secretase activity. J Neurochem 93(4): 769-92 (2005).
59. Dewji NN. The structure and functions of the presenilins. Cell Mol Life Sci 62(10): 1109-19 (2005).
60. Doan A, Thinakaran G, Borchelt DR, Slunt HH, Ratovitsky T, Podlisny M, et al. Protein topology of presenilin 1. Neuron 17(5): 1023-30(1996).
61. Laudon H, Hansson EM, Melen K, Bergman A, Farmery MR, Winblad B, et al. A nine-transmembrane domain topology for presenilin 1. J Biol Chem 280(42): 35352-60 (2005).
62. Li X and Greenwald I. Additional evidence for an eight-transmembrane- domain topology for Caenorhabditis elegans and human presenilins. Proc Natl Acad Sci USA 95(12): 7109-14 (1998).
63. Oh YS and Turner RJ. Topology of the C-terminal fragment of human presenilin 1. Biochemistry 44(35): 11821-8 (2005).
64. Oh YS and Turner RJ. Evidence that the COOH terminus of human presenilin 1 is located in extracytoplasmic space. Am J Physiol Cell Physiol 289(3): C576-81 (2005).
65. Spasic D, Tolia A, Dillen K, Baert V, De Strooper B, Vrijens S, et al. Presenilin-1 maintains a nine-transmembrane topology throughout the secretory pathway. J Biol Chem 281(36): 26569-77 (2006).
66. Selkoe DJ. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8(11): 447-53 (1998).
67. Wolfe MS. When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease. EMBO Rep 8(2): 136-40 (2007).
68. Martoglio B and Golde TE. Intramembrane-cleaving aspartic proteases and disease: presenilins, signal peptide peptidase and their homologs. Hum Mol Genet 12 Spec No 2: R201-6 (2003).
69. Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, Kim G, et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17(1): 181-190 (1996).
70. Thinakaran G, Harris CL, Ratovitski T, Davenport F, Slunt HH, Price DL, et al. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J Biol Chem 272(45): 28415-22 (1997).
71. Ratovitski T, Slunt HH, Thinakaran G, Price DL, Sisodia SS and Borchelt DR, Endoproteolytic processing and stabilization of wild-type and mutant presenilin. J Biol Chem 272(39): 24536-41 (1997).
72. Steiner H, Capell A, Pesold B, Citron M, Kloetzel PM, Selkoe DJ, et al. , Expression of Alzheimer's disease-associated presenilin-1 is controlled by proteolytic degradation and complex formation. J Biol Chem 273(48): 32322-31 (1998)
73. Levitan D, Lee J, Song L, Manning R, Wong G, Parker E, et al. PS1 N- and C-terminal fragments form a complex that functions in APP processing and Notch signaling. Proc Natl Acad Sci U. S. A. 98(21): 12186-90 (2001).
74. Esler WP, Kimberly WT, Ostaszewski BL, Diehl TS, Moore CL, Tsai JY, et al. Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1. Nat Cell Biol 2(7): 428-34 (2000).
75. Li YM, Xu M, Lai MT, Huang Q, Castro JL, DiMuzio-Mower J, et al. Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 405(6787): 689-694 (2000).
76. Brunkan AL, Martinez M, Walker ES and Goate AM. Presenilin endoproteolysis is an intramolecular cleavage. Mol Cell Neurosci 29(1): 65-73 (2005).
77. Steiner H, Kostka M, Romig H, Basset G, Pesold B, Hardy J, et al. Glycine 384 is required for presenilin-1 function and is conserved in bacterial polytopic aspartyl proteases. Nat Cell Biol 2(11): 848-51 (2000).
78. Yamasaki A, Eimer S, Okochi M, Smialowska A, Kaether C, Baumeister R, et al. The GxGD motif of presenilin contributes to catalytic function and substrate identification of gamma-secretase. J Neurosci 26(14): 3821-8 (2006).
79. Tomita T, Watabiki T, Takikawa R, Morohashi Y, Takasugi N, Kopan R, et al. The first proline of PALP motif at the C terminus of presenilins is obligatory for stabilization, complex formation, and gamma-secretase activities of presenilins. J Biol Chem 276(35): 33273-81(2001).
80. Takasugi N, Takahashi Y, Morohashi Y, Tomita T and Iwatsubo T. The mechanism of gamma-secretase activities through high molecular weight complex formation of presenilins is conserved in Drosophila melanogaster and mammals. J Biol Chem, 2002. 277(51): 50198-205 (2002).
81. Wang J, Brunkan AL, Hecimovic S, Walker E and Goate A. Conserved "PAL" sequence in presenilins is essential for gamma-secretase activity, but not required for formation or stabilization of gamma-secretase complexes. Neurobiol Dis 15(3): 654-66. (2004).
82. Kaether C, Capell A, Edbauer D, Winkler E, Novak B, Steiner H, et al. The presenilin C-terminus is required for ER-retention, nicastrin-binding and gamma-secretase activity. Embo J 23(24): 4738-48 (2004).
83. Brunkan AL, Martinez M, Wang J, Walker ES, Beher D, Shearman MS, et al. Two domains within the first putative transmembrane domain of presenilin 1 differentially influence presenilinase and gamma-secretase activity. J Neurochem 94(5): 1315-28 (2005).
84. Annaert WG, Esselens C, Baert V, Boeve C, Snellings G, Cupers P, et al. Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins. Neuron 32(4): 579-89 (2001).
85. Berezovska O, Ramdya P, Skoch J, Wolfe MS, Bacskai BJ and Hyman BT. Amyloid precursor protein associates with a nicastrin-dependent docking site on the presenilin 1-gamma-secretase complex in cells demonstrated by fluorescence lifetime imaging. J Neurosci 23(11): 4560-6 (2003).
86. Das C, Berezovska O, Diehl TS, Genet C, Buldyrev I, Tsai JY, et al. Designed helical peptides inhibit an intramembrane protease. J Am Chem Soc125 (39): 11794-5 (2003).
87. Esler WP, Kimberly WT, Ostaszewski BL, Ye W, Diehl TS, Selkoe DJ, et al. Activity-dependent isolation of the presenilin-gamma -secretase complex reveals nicastrin and a gamma substrate. Proc Natl Acad Sci USA 99(5): 2720-5 (2002).
88. Kornilova AY, Das C and Wolfe MS. Differential effects of inhibitors on the gamma-secretase complex. Mechanistic implications. J Biol Chem 278(19): 16470-3 (2003).
89. Kornilova AY, Bihel F, Das C and Wolfe MS. The initial substrate-binding site of gamma-secretase is located on presenilin near the active site. Proc Natl Acad Sci USA 102 (9): 3230-5 (2005).
90. Levesque G, Yu G, Nishimura M, Zhang DM, Levesque L, Yu H, et al. Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and beta-catenin. J Neurochem 72(3): 999-1008 (1999).
91. Nishimura M, Yu G, Levesque G, Zhang DM, Ruel L, Chen F, et al. Presenilin mutations associated with Alzheimer disease cause defective intracellular trafficking of beta-catenin, a component of the presenilin protein complex. Nat Med 5(2): 164-9. (1999).
92. Zhou J, Liyanage U, Medina M, Ho C, Simmons AD, Lovett M, et al. Presenilin 1 interaction in the brain with a novel member of the Armadillo family. Neuroreport 8(6): 1489-94 (1999).
93. Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A, et al. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature 407(6800): 48-54 (2000).
94. Fagan R, Swindells M, Overington J and Weir M. Nicastrin, a presenilin-interacting protein, contains an aminopeptidase/transferrin receptor superfamily domain. Trends Biochem Sci 26(4): 213-4 (2001).
95. Goutte C, Hepler W, Mickey KM and Priess JR. aph-2 encodes a novel extracellular protein required for GLP-1-mediated signaling. Development 127(11): 2481-92 (2000).
96. Chung HM and Struhl G. Nicastrin is required for Presenilin-mediated transmembrane cleavage in Drosophila. Nature Cell Biology 3(12): 1129-1132 (2001).
97. Hu Y, Ye Y and Fortini ME. Nicastrin is required for gamma-secretase cleavage of the Drosophila Notch receptor. Dev Cell 2(1): 69-78 (2002).
98. Lopez-Schier H and St Johnston D. Drosophila nicastrin is essential for the intramembranous cleavage of notch. Dev Cell 2(1): 79-89 (2002).
99. Li T, Ma G, Cai H, Price DL and Wong PC. Nicastrin is required for assembly of presenilin/gamma-secretase complexes to mediate Notch signaling and for processing and trafficking of beta-amyloid precursor protein in mammals. J Neurosci 23(8): 3272-7 (2003).
100. Capell A, Kaether C, Edbauer D, Shirotani K, Merkl S, Steiner H, et al. Nicastrin interacts with gamma-secretase complex components via the N-terminal part of its transmembrane domain. J Biol Chem 278(52): 52519-23 (2003).
101. Arawaka S, Hasegawa H, Tandon A, Janus C, Chen FS, Yu G, et al. The levels of, mature glycosylated nicastrin are regulated and correlate with gamma-secretase processing of amyloid beta-precursor protein. Journal of Neurochemistry 83(5): 1065-1071 (2002).
102. Kimberly WT, LaVoie MJ, Ostaszewski BL, Ye W, Wolfe MS and Selkoe DJ. Complex N-linked glycosylated nicastrin associates with active gamma-secretase and undergoes tight cellular regulation. J Biol Chem 277(38): 35113-7 (2002).
103. Yang DS, Tandon A, Chen F, Yu G, Yu H, Arawaka S, et al. Mature glycosylation and trafficking of nicastrin modulate its binding to presenilins. J Biol Chem 277(31): 28135-42 (2002).
104. Edbauer D, Winkler E, Haass C and Steiner H. Presenilin and nicastrin regulate each other and determine amyloid beta-peptide production via complex formation. Proc Natl Acad Sci USA 99(13): 8666-71 (2002).
105. Leem JY, Vijayan S, Han P, Cai D, Machura M, Lopes KO, et al. Presenilin 1 is required for maturation and cell surface accumulation of nicastrin. J Biol Chem 277(21): 19236-40 (2002).
106. Herreman A, Van Gassen G, Bentahir M, Nyabi O, Craessaerts K, Mueller U, et al. gamma-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation. J Cell Sci 116(Pt 6): 1127-36 (2003).
107. Watanabe N, Tomita T, Sato C, Kitamura T, Morohashi Y and Iwatsubo T. Pen-2 is incorporated into the gamma-secretase complex through binding to transmembrane domain 4 of presenilin 1. J Biol Chem 280(51): 41967-75 (2005).
108. Shirotani K, Edbauer D, Capell A, Schmitz J, Steiner H, and Haass C. Gamma-secretase activity is associated with a conformational change of nicastrin. J Biol Chem 278(19): 16474-7 (2003).
109. Capell A, Beher D, Prokop S, Steiner H, Kaether C, Shearman MS, et al. Gamma-secretase complex assembly within the early secretory pathway. J Biol Chem 280(8): 6471-8 (2005).
110. Francis R, McGrath G, Zhang J, Ruddy DA, Sym M, Apfeld J, et al. aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation. Dev Cell 3(1): 85-97 (2002).
111. Goutte C, Tsunozaki M, Hale VA and Priess JR. , APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos. Proc Natl Acad Sci USA 99(2): 775-9 (2002).
112. Takasugi N, Tomita T, Hayashi I, Tsuruoka M, Niimura M, Takahashi Y, et al. The role of presenilin cofactors in the gamma-secretase complex. Nature 422(6930): 438-41 (2003).
113. Lee SF, Shah S, Li H, Yu C, Han W, Yu G. Mammalian APH-1 interacts with presenilin and nicastrin and is required for intramembrane proteolysis of amyloid-beta precursor protein and Notch. J Biol Chem 277(47): 45013-9 (2002).
114. Gu Y, Chen F, Sanjo N, Kawarai T, Hasegawa H, Duthie M, et al. APH-1 interacts with mature and immature forms of presenilins and nicastrin and may play a role in maturation of presenilin. nicastrin complexes. J Biol Chem 278(9): 7374-80 (2003).
115. Hu Y and Fortini ME. Different cofactor activities in gamma-secretase assembly: evidence for a nicastrin-Aph-1 subcomplex. J Cell Biol 161(4): 685-90 (2003).
116. Kim SH, Ikeuchi T, Yu C and Sisodia SS. Regulated hyperaccumulation of presenilin-1 and the "gamma-secretase" complex. Evidence for differential intramembranous processing of transmembrane substrates. J Biol Chem 278(36): 33992-4002 (2003).
117. Shirotani K, Edbauer D, Kostka M, Steiner H and Haass C. Immature nicastrin stabilizes APH-1 independent of PEN-2 and presenilin: identification of nicastrin mutants that selectively interact with APH-1. J Neurochem 89(6): 1520-7 (2004).
118. LaVoie MJ, Fraering PC, Ostaszewski BL, Ye W, Kimberly WT, Wolfe MS, et al. Assembly of the gamma-secretase complex involves early formation of an intermediate subcomplex of Aph-1 and nicastrin. J Biol Chem 278(39): 37213-22 (2003).
119. Lee SF, Shah S, Yu C, Wigley WC, Li H, Lim M, et al. A conserved GXXXG motif in APH-1 is critical for assembly and activity of the gamma-secretase complex. J Biol Chem 279(6): 4144-52 (2004).
120. Niimura M, Isoo N, Takasugi N, Tsuruoka M, Ui-Tei K, Saigo K, et al. Aph-1 contributes to the stabilization and trafficking of the gamma-secretase complex through mechanisms involving intermolecular and intramolecular interactions. J Biol Chem 280(13): 12967-75 (2005).
121. Edbauer D, Kaether C, Steiner H and Haass C. Co-expression of nicastrin and presenilin rescues a loss of function mutant of APH-1. J Biol Chem 279(36): 37311-5 (2004).
122. Tomita T, Katayama R, Takikawa R and Iwatsubo T. Complex Nglycosylated form of nicastrin is stabilized and selectively bound to presenilin fragments. FEBS Lett 520(1-3): 117-21 (2002).
123. Shirotani K, Edbauer D, Prokop S, Haass C and Steiner H. Identification of distinct gamma-secretase complexes with different APH-1 variants. J Biol Chem 279(40): 41340-5 (2004).
124. Bergman A, Laudon H, Winblad B, Lundkvist J and Naslund J. The extreme C terminus of presenilin 1 is essential for gamma-secretase complex assembly and activity. J Biol Chem 279(44): 45564-72 (2004).
125. Fraering PC, LaVoie MJ, Ye W, Ostaszewski BL, Kimberly WT, Selkoe DJ, et al. Detergent-dependent dissociation of active gamma-secretase reveals an interaction between Pen-2 and PS1-NTF and offers a model for subunit organization within the complex. Biochemistry 43(2): 323-33 (2004).
126. Luo WJ, Wang H, Li H, Kim BS, Shah S, Lee HJ, et al. PEN-2 and APH-1 coordinately regulate proteolytic processing of presenilin 1. J Biol Chem 278(10): 7850-4 (2003).
127. Steiner H, Winkler E, Edbauer D, Prokop S, Basset G, Yamasaki A, et al. PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin. J Biol Chem 277(42): 39062-5 (2002).
128. Prokop S, Shirotani K, Edbauer D, Haass C and Steiner H. Requirement of PEN-2 for stabilization of the presenilin N-/C-terminal fragment heterodimer within the gamma-secretase complex. J Biol Chem 279(22): 23255-61 (2004).
129. Shiraishi H, Sai X, Wang HQ, Maeda Y, Kurono Y, Nishimura M, et al. PEN-2 enhances gamma-cleavage after presenilin heterodimer formation. J Neurochem 90(6): 1402-13 (2004).
130. Kim SH and Sisodia SS. A sequence within the first transmembrane domain of PEN-2 is critical for PEN-2-mediated endoproteolysis of presenilin 1. J Biol Chem 280(3): 1992-2001 (2005).
131. Hasegawa H, Sanjo N, Chen F, Gu YJ, Shier C, Petit A, et al. Both the sequence and length of the C terminus of PEN-2 are critical for intermolecular interactions and function of presenilin complexes. J Biol Chem 279(45): 46455-63 (2004).
132. Prokop S, Haass C and Steiner H. Length and overall sequence of the PEN-2 C-terminal domain determines its function in the stabilization of presenilin fragments. J Neurochem 94(1): 57-62 (2005).
133. Kim SH and Sisodia SS. Evidence that the "NF" motif in transmembrane domain 4 of presenilin 1 is critical for binding with PEN-2. J Biol Chem 280(51): 41953-41966 (2005).
134. Isoo N, Sato C, Miyashita H, Shinohara M, Takasugi N, Morohashi Y, et al. Abeta42 overproduction associated with structural changes in the catalytic pore of gamma-secretase: common effects of Pen-2 N-terminal elongation and fenofibrate. J Biol Chem 282(17): 12388-96 (2007).
135. Kim SH, Yin YI, Li YM and Sisodia SS. Evidence that assembly of an active gamma-secretase complex occurs in the early compartments of the secretory pathway. J Biol Chem 279(47): p. 48615-9 (2004).
136. Verily G, Gandy SE and Martins RN. The role of presenilin and its interacting proteins in the biogenesis of Alzheimer's beta amyloid. Neurochem Res 32(4-5): 609-23 (2007).
137. Chen F, Hasegawa H, Schmitt-Ulms G, Kawarai T, Bohm C, Katayama T, et al. TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity. Nature 440(7088): 1208-12 (2006).
138. Barr FA, Preisinger C, Kopajtich R and Korner R. Golgi matrix proteins interact with p24 cargo receptors and aid their efficient retention in the Golgi apparatus. J Cell Biol 155(6): 885-91 (2001).
139. Blum R, Feick P, Puype M, Vandekerckhove J, Klengel R, Nastainczyk W, et al. Tmp21 and p24A, two type I proteins enriched in pancreatic microsomal membranes, are members of a protein family involved in vesicular trafficking. J Biol Chem 271(29): 17183-9 (1996).
140. Li KC, Liu CT, Sun W, Yuan S and Yu T. A system for enhancing genome-wide coexpression dynamics study. Proc Natl Acad Sci USA 101(44): p. 15561-6 (2004).
141. Vetrivel KS, Gong P, Bowen JW, Cheng H, Chen Y, Carter M, et al. Dual roles of the transmembrane protein p23/TMP21 in the modulation of amyloid precursor protein metabolism. Mol Neurodegener 2: 4 (2007).
142. Spasic D, Raemaekers T, Dillen K, Declerck I, Baert V, Serneels L, et al. Rer1p competes with APH-1 for binding to nicastrin and regulates gamma-secretase complex assembly in the early secretory pathway. J Cell Biol 176(5): 629-40 (2007).
143. Kaether C, Scheuermann J, Fassler M, Zilow S, Shirotani K, Valkova C, et al. Endoplasmic reticulum retention of the gamma-secretase complex component Pen2 by Rer1. EMBO Reports Advanced Online Publication.
144. Stromberg K, Hansson EM, Laudon H, Bergstedt S, Naslund J, Lundkvist J, et al. gamma-Secretase complexes containing N- and C-terminal fragments of different presenilin origin retain normal gamma-secretase activity. J Neurochem 95(3): 880-90 (2005).
145. Hebert SS, Serneels L, Dejaegere T, Horre K, Dabrowski M, Baert V, et al. Coordinated and widespread expression of gamma-secretase in vivo: evidence for size and molecular heterogeneity. Neurobiol Dis 17(2): 260-72 (2004).
146. Herreman A, Hartmann D, Annaert W, Saftig P, Craessaerts K, Serneels L, et al. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc Natl Acad Sci USA 96(21): 11872-7(1999).
147. Lai MT, Chen E, Crouthamel MC, DiMuzio-Mower J, Xu M, Huang Q, et al. Presenilin-1 and presenilin-2 exhibit distinct yet overlapping gamma-secretase activities. J Biol Chem 278(25): 22475-81 (2003).
148. Mastrangelo P, Mathews PM, Chishti MA, Schmidt SD, Gu Y, Yang J, et al. Dissociated phenotypes in presenilin transgenic mice define functionally distinct gamma-secretases. Proc Natl Acad Sci USA 102(25): 8972-7 (2005).
149. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391(6665): 387-90 (1998).
150. Herreman A, Serneels L, Annaert W, Collen D, Schoonjans L, and De Strooper B. Total inactivation of gamma-secretase activity in presenilin-deficient embryonic stem cells. Nat Cell Biol 2(7): 461-2 (2000).
151. Zhang Z, Nadeau P, Song W, Donoviel D, Yuan M, Bernstein A, et al. Presenilins are required for gamma-secretase cleavage of beta-APP and transmembrane cleavage of Notch-1. Nat Cell Biol 2(7): 463-5 (2000).
152. Palacino JJ, Berechid BE, Alexander P, Eckman C, Younkin S, Nye JS, et al. Regulation of amyloid precursor protein processing by presenilin 1 (PS1) and PS2 in PS1 knockout cells. J Biol Chem 275(1): 215-22 (2000).
153. Serneels L, Dejaegere T, Craessaerts K, Horre K, Jorissen E, Tousseyn T, et al. Differential contribution of the three Aph1 genes to gamma-secretase activity in vivo. Proc Natl Acad Sci USA 102(5): 1719-24 (2005).
154. Ma G, Li T, Price DL and Wong PC. APH-1a is the principal mammalian APH-1 isoform present in gamma-secretase complexes during embryonic development. J Neurosci 25(1): 192-8 (2005).
155. Shirotani K, Tomioka M, Kremmer E, Haass C and Steiner H. Pathological activity of familial Alzheimer's disease-associated mutant presenilin can be executed by six different gamma-secretase complexes. Neurobiol Dis (2007).
156. Annaert W and De Strooper B. Presenilins: molecular switches between proteolysis and signal transduction. Trends Neurosci 22(10): 439-43 (1999).
157. Annaert WG, Levesque L, Craessaerts K, Dierinck I, Snellings G, Westaway D, et al. Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons. J Cell Biol 147(2): 277-94 (1999).
158. Chyung JH, Raper DM and Selkoe DJ. Gamma-secretase exists on the plasma membrane as an intact complex that accepts substrates and effects intramembrane cleavage. J Biol Chem 280(6): 4383-92 (2005).
159. Kaether C, Lammich S, Edbauer D, Ertl M, Rietdorf J, Capell A, et al. Presenilin-1 affects trafficking and processing of betaAPP and is targeted in a complex with nicastrin to the plasma membrane. J Cell Biol 158(3): 551-61 (2002).
160. Hansson EM, Stromberg K, Bergstedt S, Yu G, Naslund J, Lundkvist J, et al. Aph-1 interacts at the cell surface with proteins in the active gamma-secretase complex and membrane-tethered Notch. J Neurochem 92(5): 1010-20 (2005).
161. Bergman A, Hansson EM, Pursglove SE, Farmery MR, Lannfelt L, Lendahl U, et al. Pen-2 is sequestered in the endoplasmic reticulum and subjected to ubiquitylation and proteasome-mediated degradation in the absence of presenilin. J Biol Chem 279(16): 16744-53 (2004).
162. Kaether C, Schmitt S, Willem M and Haass C. Amyloid precursor protein and Notch intracellular domains are generated after transport of their precursors to the cell surface. Traffic 7(4): 408-15 (2006).
163. Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, et al. Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci USA 103(30): 11172-7 (2006).
164. Kaether C, Haass C and Steiner H. Assembly, trafficking and function of gamma-secretase. Neurodegener Dis 3(4-5): 275-83 (2006).
165. Pasternak SH, Callahan JW and Mahuran DJ. The role of the endosomal/lysosomal system in amyloid-beta production and the pathophysiology of Alzheimer's disease: reexamining the spatial paradox from a lysosomal perspective. J Alzheimers Dis 6(1): 53-65 (2004).
166. Haass C, Koo EH, Mellon A, Hung AY and Selkoe DJ. Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature 357(6378): 500-3 (1992).
167. Chyung JH and Selkoe DJ. Inhibition of receptor-mediated endocytosis demonstrates generation of amyloid beta-protein at the cell surface. J Biol Chem 278(51): 51035-43 (2003).
168. Knops J, Suomensaari S, Lee M, McConlogue L, Seubert P and Sinha S. Cell-type and amyloid precursor protein-type specific inhibition of A beta release by bafilomycin A1, a selective inhibitor of vacuolar ATPases. J Biol Chem 270(6): 2419-22 (1995).
169. Schrader-Fischer G and Paganetti PA. Effect of alkalizing agents on the processing of the beta-amyloid precursor protein. Brain Res 716(1-2): 91-100 (1996).
170. Siman R, Mistretta S, Durkin JT, Savage MJ, Loh T, Trusko S, et al. Processing of the beta-amyloid precursor. Multiple proteases generate and degrade potentially amyloidogenic fragments. J Biol Chem 268(22): 16602-9 (1993).
171. Chen FS, Yang DS, Petanceska S, Yang A, Tandon A. Yu G, et al. Carboxyl-terminal fragments of Alzheimer beta-amyloid precursor protein accumulate in restricted and unpredicted intracellular compartments in presenilin 1-deficient cells. J Biol Chem 275(47): 36794-36802 (2000).
172. Pasternak SH, Bagshaw RD, Guiral M, Zhang S, Ackerley CA, Pak BJ, et al. Presenilin-1, nicastrin, amyloid precursor protein, and gamma-secretase activity are co-localized in the lysosomal membrane. J Biol Chem 278(29): 26687-94 (2003).
173. Tampellini D, Magrane J, Takahashi RH, Li F, Lin MT, Almeida CG, et al. Internalized antibodies to the Abeta domain of APP reduce neuronal Abeta and protect against synaptic alterations. J Biol Chem (2007).
174. Laferla FM, Green KN and Oddo S. Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8(7): 499-509 (2007).
175. Fukumori A, Okochi M, Tagami S, Jiang J, Itoh N, Nakayama T, et al. Presenilin-dependent gamma-secretase on plasma membrane and endosomes is functionally distinct. Biochemistry 45(15): 4907-14 (2006).